Hbk Investments L P Edwards Lifesciences Corp Transaction History

Hbk Investments L P

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$52.41 - $81.0 $2.35 Million - $3.64 Million	-44,883 Reduced 95.29%	2,217 $418,000
Q4 2017 Feb 14, 2018	BUY	$33.79 - $39.39 $642,010 - $748,410	19,000 Added 67.62%	47,100 $5.31 Million
Q3 2017 Nov 14, 2017	BUY	$36.29 - $38.83 $1.02 Million - $1.09 Million	28,100	28,100 $3.07 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Hbk Investments L P, based on Form 13F filings with the SEC.

Stay updated on Hbk Investments L P with notifications on news.